Peripheral Artery Disease

A machine learning-based model ranking patient characteristics available in the electronic health record by their correlation with ankle-brachial index identified those at high risk for peripheral artery disease.

DANA POINT, Calif. — Peripheral artery disease remains underdiagnosed and undertreated among women worldwide and efforts are needed to increase awareness, improve diagnoses and ensure patient referrals, according to a speaker.

The Foundation to Advance Vascular Cures has launched a new virtual educational resource directed at medical professionals and students who are interested in approaching vascular care with a patient-centric approach.

ARLINGTON, Texas — In this Healio video exclusive, Ambarish Pandey, MD, discusses a presentation on supervised exercise training for patients with peripheral artery disease.

Warnings about excess mortality risk with paclitaxel-coated devices to treat peripheral artery disease are “no longer supported,” based on a updated review of relevant trial data, according to an FDA announcement.

The FDA has designated a recall of a peripheral catheter system as class I, the most serious kind.

Surmodics announced that the FDA has approved its low-dose paclitaxel-coated balloon for certain patients with peripheral artery disease.

Black adults are significantly more likely to develop peripheral artery disease than Hispanic or white adults even when accounting for traditional risk factors, and often present with advanced disease tied to worse outcomes like amputation.

PHILADELPHIA — Peripheral artery disease is often the first manifestation of CVD in patients with type 2 diabetes, and represents a “unique” malignant phenotype, a speaker said during the Heart in Diabetes CME Conference.

Endologix announced that the FDA has granted approval of its percutaneous transmural arterial bypass system for the treatment of complex peripheral arterial disease.